DECREASE IN HUMAN STRIATAL DOPAMINE-D2 RECEPTOR DENSITY WITH AGE - A PET STUDY WITH [C-11] RACLOPRIDE

被引:191
作者
RINNE, JO
HIETALA, J
RUOTSALAINEN, U
SAKO, E
LAIHINEN, A
NAGREN, K
LEHIKOINEN, P
OIKONEN, V
SYVALAHTI, E
机构
[1] UNIV TURKU, DEPT PHARMACOL, SF-20520 TURKU 52, FINLAND
[2] TURKU MED CYCLOTRON PET CTR, RADIOCHEM LAB, TURKU, FINLAND
关键词
AGING; D2; RECEPTORS; DOPAMINE; POSITRON EMISSION TOMOGRAPHY; RACLOPRIDE;
D O I
10.1038/jcbfm.1993.39
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of age on human striatal dopamine D2 receptors was investigated with positron emission tomography (PET) using [C-11]raclopride as a radioligand. Twenty-one healthy volunteers aged from 20 to 81 years were studied. An equilibrium method was applied and two separate PET scans with different specific activities of [C-11]raclopride were performed. The maximal number of receptors (B(max)) and their dissociation constant (K(d)) were calculated using Scatchard analysis. There was an age-dependent decline in the B(max) (r = -0.49; p = 0.02) of striatal D2 receptors while the K(d) remained unchanged. The results show that there is an age-related loss of striatal D2 receptors, which, together with other changes in the brain nigrostriatal dopaminergic system, may contribute to extrapyramidal symptoms associated with aging.
引用
收藏
页码:310 / 314
页数:5
相关论文
共 32 条
  • [1] ANTONIONI AA, 1992, MED APPL CYCLOTRONS, V6, P83
  • [2] LOSS OF STRIATAL [BR-76] BROMOSPIPERONE BINDING-SITES DEMONSTRATED BY POSITRON TOMOGRAPHY IN PROGRESSIVE SUPRANUCLEAR PALSY
    BARON, JC
    MAZIERE, B
    LOCH, C
    CAMBON, H
    SGOUROPOULOS, P
    BONNET, AM
    AGID, Y
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1986, 6 (02) : 131 - 136
  • [3] CARLSSON A, 1980, PARKINSONS DISEASE C, P121
  • [4] AGE-RELATED-CHANGES IN THE HUMAN NIGROSTRIATAL DOPAMINERGIC SYSTEM
    DEKEYSER, J
    EBINGER, G
    VAUQUELIN, G
    [J]. ANNALS OF NEUROLOGY, 1990, 27 (02) : 157 - 161
  • [5] STEREOSELECTIVE BINDING OF 11C-RACLOPRIDE IN LIVING HUMAN-BRAIN - A SEARCH FOR EXTRASTRIATAL CENTRAL D2-DOPAMINE RECEPTORS BY PET
    FARDE, L
    PAULI, S
    HALL, H
    ERIKSSON, L
    HALLDIN, C
    HOGBERG, T
    NILSSON, L
    SJOGREN, I
    STONEELANDER, S
    [J]. PSYCHOPHARMACOLOGY, 1988, 94 (04) : 471 - 478
  • [6] FARDE L, 1990, ARCH GEN PSYCHIAT, V47, P213
  • [7] QUANTITATIVE-ANALYSIS OF D2 DOPAMINE RECEPTOR-BINDING IN THE LIVING HUMAN-BRAIN BY PET
    FARDE, L
    HALL, H
    EHRIN, E
    SEDVALL, G
    [J]. SCIENCE, 1986, 231 (4735) : 258 - 261
  • [8] KINETIC-ANALYSIS OF CENTRAL [C-11] RACLOPRIDE BINDING TO D2-DOPAMINE RECEPTORS STUDIED BY PET - A COMPARISON TO THE EQUILIBRIUM-ANALYSIS
    FARDE, L
    ERIKSSON, L
    BLOMQUIST, G
    HALLDIN, C
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1989, 9 (05) : 696 - 708
  • [9] CENTRAL DOPAMINERGIC PATHWAYS IN HEMIPARKINSONISM EXAMINED BY POSITRON EMISSION TOMOGRAPHY
    GARNETT, ES
    NAHMIAS, C
    FIRNAU, G
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) : 174 - 179
  • [10] HUMAN DOPAMINE RECEPTOR SUBTYPES - INVITRO BINDING ANALYSIS USING H-3 SCH 23390 AND H-3 RACLOPRIDE
    HALL, H
    FARDE, L
    SEDVALL, G
    [J]. JOURNAL OF NEURAL TRANSMISSION, 1988, 73 (01) : 7 - 21